391 related articles for article (PubMed ID: 23810804)
21. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
[TBL] [Abstract][Full Text] [Related]
22. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons.
Chen X; Huang T; Zhang J; Song J; Chen L; Zhu Y
Brain Res; 2008 Mar; 1200():99-106. PubMed ID: 18289510
[TBL] [Abstract][Full Text] [Related]
23. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
24. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
25. [Generation of Tau/App/PS1 triple-transgenic mouse model and the study of its biological characteristics].
Wang LL; Na X; Zhu XN; Chen RZ; Wang H; Wang XL
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jul; 28(4):294-7. PubMed ID: 23156717
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
27. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
28. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
Götz J; Chen F; van Dorpe J; Nitsch RM
Science; 2001 Aug; 293(5534):1491-5. PubMed ID: 11520988
[TBL] [Abstract][Full Text] [Related]
29. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
[TBL] [Abstract][Full Text] [Related]
30. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
Crespo-Biel N; Canudas AM; Camins A; Pallàs M
Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
[TBL] [Abstract][Full Text] [Related]
31. Mouse models of Alzheimer's disease: the long and filamentous road.
Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
[TBL] [Abstract][Full Text] [Related]
32. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
[TBL] [Abstract][Full Text] [Related]
33. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
35. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
36. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
[TBL] [Abstract][Full Text] [Related]
37. Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer's disease mouse model.
He Y; Pan S; Xu M; He R; Huang W; Song P; Huang J; Zhang HT; Hu Y
FASEB J; 2017 Aug; 31(8):3383-3392. PubMed ID: 28420695
[TBL] [Abstract][Full Text] [Related]
38. [Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer's disease senile plaques and neuritic dystrophy in APP/PS1 transgenic mice].
Zhao XY; Wang DD; Shan Y; Zhu CQ
Sheng Li Xue Bao; 2013 Jun; 65(3):253-62. PubMed ID: 23788181
[TBL] [Abstract][Full Text] [Related]
39. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.
Brion JP; Tremp G; Octave JN
Am J Pathol; 1999 Jan; 154(1):255-70. PubMed ID: 9916940
[TBL] [Abstract][Full Text] [Related]
40. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]